Evidence map›Paper›PMID 26510432›Full record

ReviewCurrent pharmaceutical design2015

The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics.

Alejandra Valdivia, Charity Duran, Alejandra San Martin

Abstract readReview
In one paragraph

Review in Current pharmaceutical design, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fundamentals of redox regulation in biology.Nature reviews. Molecular cell biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Adherence ofMicroorganisms · 2020
    Article
  17. Article
  18. Focal Accumulation of ROS Can BlockInternational journal of molecular sciences · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alejandra Valdivia
Charity Duran
Alejandra San MartinEmory University, Department of Medicine, Division of Cardiology, 308C WMB, 101 Woodruff Circle, Atlanta, GA 30322. asanmartin@emory.edu.
Emory Healthcare · US

Funding

Research Trainng in Academic CardiologyT32HL007745 · NHLBI · EMORY UNIVERSITY · PI TAYLOR, WILLIAM ROBERT · 1994 to 2023
$10.6M
Mechanically Stressed VSMC: A Role for Slingshot Phosphatase in InflammationR01HL113167 · NHLBI · EMORY UNIVERSITY · PI SAN MARTIN, ALEJANDRA · 2013 to 2017
$1.9M
Mechanism of SSH1L Phosphatase Activation in VSMC: Role in Vascular PathologyR00HL093115 · NHLBI · EMORY UNIVERSITY · PI SAN MARTIN, ALEJANDRA · 2009 to 2011
$747k
NHLBI NIH HHS R00 HL093115NHLBI NIH HHS R01 HL113167NHLBI NIH HHS R01HL113167NHLBI NIH HHS T32 HL007745NHLBI NIH HHS T32HL007745
6 · The paper itself

Abstract

Nox generated ROS, particularly those derived from Nox1, Nox2 and Nox4, have emerged as important regulators of the actin cytoskeleton and cytoskeleton-supported cell functions, such as migration and adhesion. The effects of Nox-derived ROS on cytoskeletal remodeling may be largely attributed to the ability of ROS to directly modify proteins that constitute or are associated with the cytoskeleton. Additionally, Nox-derived ROS may participate in signaling pathways governing cytoskeletal remodeling. In addition to these more extensively studied signaling pathways involving Nox-derived ROS, there also exist redox sensitive pathways for which the source of ROS is unclear. ROS from as of yet undetermined sources play a role in modifying, and thus regulating, the activity of several proteins critical for remodeling of the actin cytoskeleton. In this review we discuss ROS sensitive targets that are likely to affect cytoskeletal dynamics, as well as the potential involvement of Nox proteins.

Indexed as

CytoskeletonHumansNADPH OxidasesOxidation-ReductionReactive Oxygen SpeciesNADPH OxidasesReactive Oxygen Species

Identifiers

PMID26510432
PMCPMC4699303
OpenAlexW2099875681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.